Canine atopic dermatitis is a common skin disorder in dogs. It is a hereditary skin disease that is associated with IgE antibodies to environmental allergens. The disease is characterized by pruritic lesions that develop on the skin and is a chronic condition. Cytopoint (lokivetmab), an injectable monoclonal antibody (mAb) that blocks cytokine interleukin-31, is used to treat the skin disorder.
Cytopoint is a long-lasting treatment that can help dogs suffering from atopic dermatitis. The injections are given to dogs by their veterinarians. This treatment is effective for dogs of all ages.
Canine atopic dermatitis injections are a new option for treating canine atopic dermatitis. The treatment has been deemed safe and effective by the U.S. Department of Agriculture, and is licensed for veterinary use.
Canine atopic dermatitis involves a cycle of itch and inflammation. In addition to allergic reactions, dogs also are susceptible to secondary microbial infections. Since the skin barrier is defective, these organisms can easily penetrate the skin, triggering an inflammatory response. A multimodal approach is necessary for effective treatment.
An allergy shot is an intradermal immunotherapy that uses a tiny amount of allergens. These shots are given every few weeks for the first few months. Although they are relatively safe, they can cost quite a bit of money.
However, these treatments are not suitable for all dogs with atopic dermatitis. Some dogs have a reaction to the shots, and some have a negative result. For these cases, a more convenient alternative is the allergen immunotherapy system (ASIS).
ASIS works by introducing a limited amount of allergens into the dog’s bloodstream biweekly. As the immune system is desensitized, the reactivity to the allergens is reduced.